Physician profile
Dmitry Novoseletsky
NPI 1043230345
$1,706.80
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2021: $350 · 2022: $18.14 · 2023: $72.81 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,215.28 | 2019-2021 | |
| Boston Scientific Corporation | $203.40 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $81.26 | 2024 | Exparel, Iovera |
| Depuy Synthes Sales INC. | $50.54 | 2022-2024 | Monovisc, Orthovisc |
| Nevro Corp. | $38.96 | 2019 | |
| Kerecis Limited | $31.55 | 2021 | |
| Medtronic, INC. | $23.56 | 2021 | |
| Collegium Pharmaceutical, INC. | $19.24 | 2021 | |
| Vivus LLC | $18.57 | 2024 | Qsymia |
| Ermi LLC | $16.45 | 2019 | |
| Sonex Health, INC. | $7.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitry Novoseletsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.